QCM
COLL icon

Quantinno Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Quantinno Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.57M Buy
98,592
+42,350
+75% +$1.45M ﹤0.01% 1512
2026
Q1 		$1.86M Buy
56,242
+37,213
+196% +$1.58M ﹤0.01% 1672
2025
Q4 		$881K Buy
19,029
+4,389
+30% +$184K ﹤0.01% 1898
2025
Q3 		$512K Buy
14,640
+4,208
+40% +$146K ﹤0.01% 1999
2025
Q2 		$308K Buy
+10,432
New +$298K ﹤0.01% 1997

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Quantinno Capital Management's COLL Position: Q2 2026 in Review

Quantinno Capital Management increased its Collegium Pharmaceutical (COLL) stake by 75% in Q2 2026, buying an estimated $1.45M and bringing the position to 98,592 shares worth $3.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1512.

Quantinno Capital Management first reported a position in COLL in Q2 2025 and has held it in 5 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Quantinno Capital Management held 98,592 shares of Collegium Pharmaceutical worth $3.57M as of Q2 2026.
  • Quantinno Capital Management bought 42,350 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.45M.
  • Collegium Pharmaceutical made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1512 holding.
  • Quantinno Capital Management first reported a position in Collegium Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.